- Mohammad Ebrahim Parsanezhad
 - - Department of Obstet . and Gynecol Faculty of Medicine, Shiraz Medical Sciences University, Shiraz, Iran
- Saeed Alborzi
- - Department of Obstet . and Gynecol Faculty of Medicine, Shiraz Medical Sciences University, Shiraz, Iran
- Shohreh RostamSoolat
- - Department of Obstet . and Gynecol Faculty of Medicine, Shiraz Medical Sciences University, Shiraz, Iran
- Elham Kokabi
- - Department of Obstet . and Gynecol Faculty of Medicine, Shiraz Medical Sciences University, Shiraz, Iran
Received: 4/1/2000 Accepted: 4/1/2000 - Publisher : Avicenna Research Institute |
|
| Related Articles |
|
| Other Format |
|
|
|
Abstract
Incidence of infertility is approximately 10-15% (11.2% in Shiraz). Anovulation is about 40% of female infertility (46% in Shiraz). PCOD, is the most common cause of anovulation (81.5% in Shiraz) . Clomiphen citrate (CC) is the first line of treatment, but approximately 20% of patients with PCO fail to ovulate with the highest dose of CC. These patients have good response to bromocriptine. The purpose of this study is to evaluate the role of bromocriptine in CC - resistant patient with PCOD. Between March 1997 to July 1999, 43 women, who were considered to have PCOD with normal serum prolactin and also CC failure, were studied in infertility division of Shiraz University of Medical Sciences. They were treated with CC 200mg daily from 5th to 9th day of the cycle and Bromocriptine 2.5mg twice daily for at least 3 months. Hormonal assay (FSH, LH, PRL, DHEA-So4 Testosterone, progesterone) and also clinical changes were monitored pre and post treatment. After treatment 40% of the patient had regular menses and 30% conceived. There was significant decrease in PRL from 269.9 mIU/ml to 174 mIU/ml (p<0.001 ), lh from 17.9 to 11.5 (p<0.001) and lh sh ratio from 2.4 to 1.5 (p<0.001). the result suggests that the therapeutic effects of this treatment may be primarily due to the restoration and improvement of the impaired hypothalamus - pituitary axis.< pan>
Keywords:
Infertility, Syndrome, Bromocriptine, Clomid Resistant Polycystic Ovary To cite this article:References
- Tielemans E, Burdorf A, Velde ER. Occupationally related exposures and reduced semen quality: a case control study, Fertil- Steril. 1999;7(4):690-696.
- Kelestimur F, Unluhizarei K, Bayram- F. Metformin and PCOS, Clin Endocrinal (OXF). 2000;52(2):244-246.
- Speroff L, Glass RH, Kase NG. Clinical Gynecologic Endocrinology and infertility. 1999;6th ed, Williams and Willkins Co.
- Parsanezhad ME, Alborzi S. Epidemiologic and etiologic aspects of infertility. Yazd University of Medical Sciences Journal Specific issue on infertility. 1998;pp:58-64, Summer.
- Mac Kenna TJ. Pathogenesis and Treatment of PCOS. 1998; New England Journal Med, 318:558-62.
- Hershlag A, Petterson CM: Endocrine disorder in Novak?s Gynecology 12th ed. Williams & Wilkins CO. 1998;pp:833-86.
- Kase NG, Lanfer N: An ovulation in Principle and practice of Clinical gynecology 2nd ed. Churchil livingstone, Co. 1990;pp:363-76.
- Carmina E, Rostao F, Maggiore M, Prolactin secretion in PCOS, correlation with steroid Pattern. Acta Endocrinol. 1984;105-99.
- Judd SJ, Rigg LA. Yen SSC: The effects of Ovariectory and estrogen treatment on the dopamine inhibition of gonadotropin and prolactin release. Journal Clin Endocrinol Metab. 1979;49:182.
- Quigley ME, Rakoff SJ, Yen SSC: increased LH sensitivity to dopamine inhibition in PCOS, Journal Clin Endocrinol Metab. 1981;52:231.
- Thorner MO, Besser GM, Jones A, Bromocriptine treatment of female infertility: Report of 13 pregnancies. Br Med Journal. 1975;4:694.
- Spruce BA, Kendall-Taylor P, Dunlop W, The effect of bromocriptine in the polycystic ovary syndrome. Clin Endocrinol. 1984;20:281.
- Seibel MM, Oskowitz S, Kamrava M, Bromocriptine response in normoprolactinemic Patients with Polycystic ovary disease. A Proliminary report. Obstet Gynecol. 1984;64:213.
- Wildt L, Hausler A, Marshall G, Frequency and amplitude of gonadotropin releasing hormone stimulation and gonadotropin secretion in the Rhesus monkey. Endocrinology. 1981;109:376.
- Devane G.W., Guzick D.S. Bromocriptine therapy in normoprolactinemic women with unexplained infertility and galactorrhea. Fertility and sterility. 1986;vol46:No6:1026-1031.
- Bromocriptine treatment of women with clomiphene-resistant polycystic ovary syndrome. Clinical Endocrinoloy. 1987;26:197-203.
- Seibel MM, Oskowitz S, Kamrava M, Bromocriptine response in normoprolactinemic. Patients with polycystic ovary disease. Obstetrics and Gynecology. 1984;64:213-218.
- Procile A, Gallardo E, Venegas E: Normoprolactinemic anovulation non responsive to clomiphene citrate, ovulation induction with bromocriptine. Fertility and Sterility. 1990;vil53:No 1:50-55.
- Suginami H, Hamadak Y, Kuroda G, Ovulation induction with bromocriptine in normoprolactinemic anovaltory women: Journal of Clinical Endocrinology and Metabolism. 1985;62:899-903.
- Franks S, Adams J, Mason H, Polson D. Ovulatory disorders in women with PCOD Clinics in OBS & GyN. 1985;pp:605-631.
- Kolike K, Aono T, Miyalke A, Tsutsumi H, Matsumoto K: Induction of Ovulation in patients with normoprolactinemic amenorrhea by combined therapy with bromocriptin and clomiphene. Fertil- Steril. 1981;35:138.
- Corenbulum B, Taylor PJ. A rationable for the use of bromocriptin in patients with amenorrhea and normprolactinemia. Fertil- Steril. (1980);34:239.
- Falachi P, Rocco A, Del Pozo E. Inhibitory Effect of bromocriptine Treatment on Luteinizing Hormone Secretion in PCOS: Journal of Clinical Endocrinology and Metabolism. 1986;62(2):348-51.
- Tabbakh G, Loutfi IA, Azab I, Bromocriptin in PCOD: A Controlled Clinical Trial: Obstet & Gynecol. 1988;71(3):301-306.